Sosei : Heptares to receive US$2 5 million milestone payment from Formosa Pharmaceuticals marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Sosei Heptares Operational Highlights and Consolidated Results for the 12 Months ended 31 December 2020
News provided by
Share this article
Share this article
TOKYO and CAMBRIDGE, England, Feb. 12, 2021 /PRNewswire/ Sosei Group Corporation ( the Company ) (TSE: 4565) provides an update on operational activities and reports its consolidated results for the 12 months ended 31 December 2020. The full report can be accessed by clicking here.
Shinichi Tamura, Chairman, President and CEO of Sosei Heptares, commented: Sosei Heptares made a great deal of progress across all areas of its business in 2020, despite the challenges we faced. We adapted extremely well to the COVID-19 pandemic. This allowed us to successfully execute our strategy, adding several major partnering agreements around our early-stage programs, reinforcing our position as a leading go-to drug discovery and development partner. We also entered several strategic technology collaborations with innovative companie
Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting Immune Disorders of the Digestive System
- Single-target agreement focused on small molecule agonists of GPR35, a genetically validated target for inflammatory bowel disease and other gastrointestinal immune disorders
- Sosei Heptares eligible to receive an upfront payment, research funding and potential near-term development milestones of up to £34 million (US$44 million), potential downstream payments of up to £336 million (US$437 million) and tiered royalties
News provided by
Share this article
Share this article
TOKYO and CAMBRIDGE, England, Dec. 21, 2020 /PRNewswire/ Sosei Group Corporation ( the Company ) (TSE: 4565) announces it has entered into a global collaboration and license agreement with GlaxoSmithKline ( GSK )